Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
43 results about "Increase blood pressure" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Positive pressure systems and methods for increasing blood pressure and circulation
InactiveUS20050165334A1Enhance blood flow blackEnhances vital organ circulationElectrotherapyElectrocardiographyBlood flowPositive pressure
In one embodiment, the invention provides a medical method for treating a person and comprises repeatedly compressing the person's chest. While repeatedly compressing the person's chest, the method further includes repeatedly delivering a positive pressure breath to the person and extracting respiratory gases from the person's airway using a vacuum following the positive pressure breath to create an intrathoracic vacuum to lower pressures in the thorax and to enhance blood flow back to the heart.
Owner:ZOLL MEDICAL CORPORATION
Positive pressure systems and methods for increasing blood pressure and circulation
InactiveUS7766011B2Reduce pressureImprove efficiencyElectrotherapyElectrocardiographyPositive pressureBreathing gas
In one embodiment, the invention provides a medical method for treating a person and comprises repeatedly compressing the person's chest. While repeatedly compressing the person's chest, the method further includes repeatedly delivering a positive pressure breath to the person and extracting respiratory gases from the person's airway using a vacuum following the positive pressure breath to create an intrathoracic vacuum to lower pressures in the thorax and to enhance blood flow back to the heart.
Owner:ZOLL MEDICAL CORPORATION
Devices, systems and methods for controlling local blood pressure
The present invention discloses devices, systems and methods for increasing blood pressure in a blood vessel by introducing an anchor within that traps a particle capable of increasing in volume as it is exposed to blood flow. As the particle increases in volume, it serves to decrease the cross sectional area of the blood vessel, resulting in decreased blood flow and increased blood pressure. This invention may be used to arterialize blood vessels in the venous system to prepare them for an exposure to arterial pressures.
Owner:DTHERAPEUTICS
Method of Treatment Using Alpha-1-Adrenergic Agonist Compounds
ActiveUS20100113377A1Prevents increase amountIncrease the areaBiocideSugar derivativesAdrenergic receptor agonistsΑ adrenergic
Methods for treating or preventing cardiomyopathy in a subject by administering an al adrenergic receptor agonist, wherein the treatment does not result in increased blood pressure are provided.
Owner:RGT UNIV OF CALIFORNIA
Artificial heart blood-pump capable of increasing blood pressure step by step
The invention discloses a mechanical heart blood pump which boosts blood pressure steps by steps, pertaining to the technical field of biomedical engineering, relating to a mechanical heart blood pump for boosting blood pressure. The mechanical heart blood pump comprises a driving stator and a rotor; a controller connected with a driving stator provides a driving power source; the driving stator composed of annular coils is located in an interlayer composed of a cylindrical shell 13 and a tubular cavity 10; a supporting rotor comprises a head guide vane 1 and a tail guide vane 8; the head guide vane 1 is arranged in the front end of the tubular cavity 10, the tail guide vane 8 is arranged in the rear end of the tubular cavity 10 and a rotor between the head guide vane 1 and the tail guide vane 8 is also arranged in the tubular cavity 10. The mechanical heart blood pump is characterized in that: the mechanical heart blood pump is divided into a front grade and a rear grade, wherein, the front grade is a Grade 1 blood pump and the rear grade is a Grade 2 blood pump; the Grade 1 blood pump and the Grade 2 blood pump are respectively driven by the controller. The blood firstly flows through the Grade 1 blood pump to generate a blood pressure and then flows through the Grade 2 blood pump to generate another blood pressure; the two blood pressures are overlaid to reach a blood pressure needed by the human body, thus avoiding the problem that red blood cells are injured by the rotational speed increase of an impeller when a single blood pump works to obtain a relatively high blood pressure.
Owner:BEIJING UNIV OF TECH
Benzoimidazole-carboxylic acid amide derivatives as APJ receptor modulators
The present invention relates to benzoimidazole-carboxylic acid amide compounds of the formula I, in which R′, R″, R′″, R1, R2, R3, R4, R5, R6 and Z are defined as indicated below. The compounds of the formula I are APJ receptor modulators, and are useful for the treatment of diseases associated with increased blood pressure for example. The invention furthermore relates to the use of compounds of the formula I, in particular as active ingredients in pharmaceuticals, and pharmaceutical compositions comprising them.
Owner:SANOFI SA
Drug recommendation method, device and server based on literature data
ActiveCN106156482AIncrease awarenessHigh blood pressureMedical data miningComputer-assisted medicine prescription/deliveryCognitionIsomerisms
The invention provides a drug recommendation method, device and server based on literature data. The method includes the steps that abstract data of all articles in a biomedicine literature database is obtained; an abstract database of articles related to a certain special people group with hypertension is set up by limiting medical subject headings; data indexes for evaluating quality of the articles related to the certain special people group with hypertension are set up; the article, author, periodical and print type in all the articles related to the certain special people group with hypertension and information of various kinds of antihypertensive drugs are extracted according to the abstract database; weighted isomerism graphs are constructed according to the extracted information and the data indexes; the weighted isomerism graphs are sorted, and ranking information of the antihypertensive drugs suitable for the certain special people group with hypertension is obtained. The method can recommend ranking information of the antihypertensive drugs suitable for the various special people groups to improve the cognition degree to use conditions of the antihypertensive drugs of grass-roots doctors, increase blood pressure rate of reaching the standard and improve the current situation of poor control over hypertension.
Owner:袁洪
Low-sugar wafer biscuit
InactiveCN104068082ADoes not raise blood pressureDoes not raise blood sugarBakery productsBiotechnologySucrose
The invention relates to a low-sugar wafer biscuit and belongs to the technical field of food processing. The low-sugar wafer biscuit mainly contains flour, corn starch, stevia extract, medlar powder, peanut meal, whole milk powder, olive oil, salt, swelling agent and the like. The low-sugar wafer biscuit is rich of protein, does not contain sucrose, does not increase blood pressure, blood glucose and blood fat after being eaten for a long period of time and is suitable for various populations.
Owner:NANJING ZELANG AGRI DEV
Nerve-soothing blood-pressure-reducing traditional Chinese medicine tea
The invention relates to a blood-pressure-treating traditional Chinese medicine composition, and specifically relates to a nerve-soothing blood-pressure-reducing traditional Chinese medicine tea. The invention provides the tea aiming at solving a series of health problems caused by increased blood pressure due to higher mental dysfunction caused by fast life pace, increased work pressure, and inappropriate diet and rest. The nerve-soothing blood-pressure-reducing traditional Chinese medicine tea is composed of the raw materials, by weight: 30-120 parts of mulberry leaves, 25-125 parts of hawthorn leaves, 20-100 parts of eucommia leaves, 20-100 parts of Japanese pogodatree flower, 15-75 parts of white chrysanthemum, 10-50 parts of Szechwan lovage rhizome, 10-50 parts of obtuseleaf senna seed, and 10-50 parts of ginkgo leaves. When the nerve-soothing blood-pressure-reducing tea provided by the invention is taken for a long time, human body functioning can be gradually improved. The tea has the functions of human central nervou regulating, fatigue relieving, sleep promoting, body immunity enhancing, human body self-regulation enhancing, and blood pressure fluctuation suppressing.
Owner:康禾椹科技有限公司
Artificial heart blood-pump capable of increasing blood pressure step by step
InactiveCN101361994BReduce resistanceAvoid destructionRadial flow pumpsSuction devicesImpellerRed blood cell
Owner:BEIJING UNIV OF TECH
Device, And A Method For Treatment Of Increased Blood Pressure
Methods and devices are presented which act by cutting the renal nerves slowly through. The minimally invasive implantable devices can be delivered through state of the art delivery catheters into the renal arteries as known from stenting, and do not require external generators, thereby being easily to introduce in normal equipped radiology catheter labs.
Owner:SYNTACH AG
Devices, Systems and Methods for Controlling Local Blood Pressure
ActiveUS20080195138A1Increase in interior blood pressureGood blood pressureStentsDilatorsVeinDecreased mean arterial pressure
The present invention discloses devices, systems and methods for increasing blood pressure in a blood vessel by introducing an anchor within that traps a particle capable of increasing in volume as it is exposed to blood flow. As the particle increases in volume, it serves to decrease the cross sectional area of the blood vessel, resulting in decreased blood flow and increased blood pressure. This invention may be used to arterialize blood vessels in the venous system to prepare them for an exposure to arterial pressures.
Owner:DTHERAPEUTICS
Catestatin (CST) and its variants for treatment of cardiovascular and metabolic disorders
InactiveUS20110166066A1Good blood pressurePeptide/protein ingredientsDisease diagnosisChromograninsWild type
Circulating levels of catestatin (Cts: human chromogranin A352-372) decrease in the plasma of patients with essential hypertension. Genetic ablation of the chromogranin A (Chga) gene in mice increases blood pressure and pre-treatment of Chga-null mice with Cts prevents blood pressure elevation, indicating a direct role of Cts in preventing hypertension. This notable vasoreactivity prompted us to test the direct cardiovascular effects and mechanisms of action of wild-type Cts (WT-Cts) and naturally occurring human variants (G364S-Cts and P370L-Cts) on myocardial and coronary functions. The cardio-inhibitory influence exerted on basal mechanical performance and the counter-regulatory action against beta-adrenergic and ET-1 stimulations, point to Cts as a novel cardiac modulator, able to protect the heart against excessive sympathochromaffin over-activation, e.g. hypertensive cardiomyopathy.
Owner:RGT UNIV OF CALIFORNIA
A method for treating haemorrhage, shock and brain injury
InactiveCN105705151ANervous disorderHydroxy compound active ingredientsInjury brainLocal anaesthetic
The invention relates to a composition and method for increasing blood pressure, including a low pain or analgesic state or hypotensive anaesthesia in a subject that has suffered a life threatening hypotension or shock or reducing hypofusion in the whole body of a subject. The composition comprises (i) a compound selected from at least one of a potassium channel opener, a potassium channel agonist and an adenosine receptor agonist; and (ii) an antiarrhythmic agent or a local anaesthetic.
Owner:低温药理KF有限公司
Approaches to venous occlusion for embolus management
Owner:DUHAY FRANCIS
Opioid antagonist compounds and methods of making and using
ActiveUS9650338B1Good blood pressureReduce cravingsOrganic chemistryPharmaceutical delivery mechanismOpioid antagonistPentazocine
The present invention is aimed at providing an opioid antagonist compound and preparation method thereof, and its medical use. The medical use for opioid antagonists such as the compound of formula (I) (shown below) include complete or partial reversal of narcotic depression, including respiratory depression, induced by opioids including natural and synthetic narcotics, such as heroin, fentanyl, oxycodone, hydrocodone, morphine, propoxyphene, methadone and certain narcotic-antagonist analgesics, such as nalbuphine, pentazocine and butorphanol. An opioid antagonist may also be useful as an adjunctive agent to increase blood pressure in the management of septic shock. Further, opioid antagonists also have been shown to reduce the craving for alcohol.
Owner:VDM BIOCHEM INC
Stable pharmaceutical composition of vasopressin
ActiveUS11318183B2Maintain stabilityIncrease pressurePeptide/protein ingredientsPharmaceutical delivery mechanismVascular dilationPharmaceutical medicine
Owner:MANKIND PHARMA LTD
NO donor-type hydrocortisone derivative, its preparing method and antiphlogistic use
InactiveCN101012265AGood anti-inflammatory activityGood treatment effectOrganic active ingredientsAntipyreticCortisoneMedicine
The invention discloses hydrogenated cortisone derivant from NO as compound I in the medical chemical domain, which reserves or reinforces anti-inflammatory action and lessens the bad reaction of elevation of blood pressure and osteoporosis.
Owner:JIANGSU YUNYANG PHARMA GRP
Preparation method of mixed unpolished rice-buckwheat nutrition porridge
InactiveCN106418153AIncrease nutritional contentHigh nutritional valueFood freezingNatural extract food ingredientsPolygonum fagopyrumNutritive values
The invention provides a preparation method of unpolished rice-buckwheat mixed nutrition porridge. The unpolished rice is used so as to improve nutritional compositions of the grains. The preparation method of the unpolished rice-buckwheat mixed nutrition porridge comprises the following steps: pre-treating the unpolished rice, namely freezing the unpolished rice at 5 DEG C below zero so as to cause a small amount of damages to the unpolished rice grains, so that bee-ball-shaped small holes are formed on the unpolished rice grains; and then, treating the pre-treated unpolished rice in a treatment solution which has been prepared in advance, so that the unpolished rice grains are infiltrated by active ingredients of the treatment solution, and the nutritive values of the unpolished rice are thereby improved. The treatment solution prepared in advance is prepared from the following main ingredients: bananas, lemons and paper mulberry fruits; the bananas and the lemons are common fruits; the bananas are rich in potassium and magnesium contents, wherein the potassium is capable of preventing increased blood pressure and muscle spasm, and the magnesium has the effect of relieving fatigue; the lemons are rich in citric acid and vitamin C contents; and the paper mulberry fruits can be directly eaten or used as a traditional Chinese medicine after treatment, and have good effects of reinforcing the bones and muscles, as well as sterilizing. The mixed use of the bananas, the lemons and the paper mulberry fruits has obvious effects of improving movement functions of the people who exercise regularly.
Owner:李志军
Noninvasive angioplasty using momentary vacuum therapy
InactiveUS7513879B2Prevents the breakdown of these chemical messagesIncrease elasticityElcosanoid active ingredientsDiagnosticsDiseaseFunctional disturbance
Noninvasive angioplasty using momentary vacuum therapy (MVT) is applied to treat erectile dysfunction, peripheral artery disease, and deep vein thrombosis. MVT is a noninvasive angioplasty technique which momentarily increases blood pressure to flatten arterial plaque and increase arterial elasticity for peripheral artery disease and deep vein thrombosis. The workload on the heart will be reduced by the flattening of plaque and the increase in elasticity of the peripheral arteries. The reduction in workload may be a treatment for congestive heart failure (heart failure). For treating erectile dysfunction, MVT increases the elasticity of penile arteries but does not flatten penile plaque; when treating erectile dysfunction with MVT, only an increase in arterial elasticity is required.
Owner:KOENIG J FR +1
Compositions and Methods for Treatment of Neurological Symptoms Associated with Alcohol-Withdrawal and for Consulsive Seizure
ActiveUS20080286209A1Wide range of activitiesEffective treatmentBiocideNervous disorderNervous systemNerolidol
Particular aspects of the present invention provide pharmaceutical compositions comprising isoprenoid-based compounds (e.g., farnesol and / or farnesol analogues or derivatives) or dehydroisoprenoid-based compounds, and novel methods for using same in treating (e.g., suppressing): alcohol withdrawal syndrome and associated neurological symptoms (e.g., depression, tremor, anxiety, autonomic hyperactivity (e.g., sweating, increased blood pressure, tachycardia), hallucinations, alcohol withdrawal seizures, delirium tremens (DT), and memory loss); or for treating in treating convulsive seizure (e.g., epileptic seizure, etc.). Particular pharmaceutical compositions and methods comprise the use of at least one compound selected from the group consisting of: (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol (all-trans farnesol); (2Z,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol (cis-farnesol); (E)-3,7,11-trimethyldodeca-1,6,10-trien-3-ol nerolidol); (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-amine (farnesylamine); (E)-3-(3,7-dimethylocta-2,6-dienyloxy)phenol (geranylresorcinol); (2E,6E)-,7,11-dimethyl-3-(trifluoromethyl)dodeca-2,6,10-trien-1-ol (trifluorofarnesol); and (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraen-1-ol (all-trans retinol). According to additional aspects, compounds that target and inhibit enzymes that degrade / metabolize / inactivate the disclosed compounds have utility to induce endogenous accumulation thereof to suppress / prevent, e.g., alcohol withdrawal seizures or convulsive seizures.
Owner:OREGON HEALTH & SCI UNIV
Pharmaceutical composition for treating hypotension
InactiveCN105616932AIncrease excitabilityImprove diastolic center functionCardiovascular disorderPlant ingredientsSide effectRadix Aconiti
The invention relates to a pharmaceutical composition for treating hypotension, and belongs to the technical field of traditional Chinese medicine. The pharmaceutical composition consists of the following traditional Chinese medicinal materials in parts by weight: 10-20 parts of radix angelicae sinensis, 20-35 parts of radix codonopsis, 20-40 parts of radix astragali, 10-30 parts of rhizoma ligustici wallichii, 10-15 parts of radix aconiti carmichaeli, 8-12 parts of cassia twig, 10-15 parts of white atractylodes rhizome, 10-15 parts of dried orange peel, 10-15 parts of radix bupleuri, 15-20 parts of radix glycyrrhizae preparata and 10-20 parts of rhizoma cimicifugae. The pharmaceutical composition for treating hypotension disclosed by the invention is scientific in compatibility and easily available in raw material; the pharmaceutical composition is capable of warming and activating yang, tonifying spleen and invigorating spleen, and the pharmaceutical composition is conducive to the improvement of the excitability of a central nervous system and is capable of improving vasomotor center functions; the pharmaceutical composition is beneficial for increasing blood pressure and improving clinical symptoms; and the pharmaceutical composition is significant and reliable in efficacy and is free from side effects.
Owner:王娟
Mitochondrial modulation to improve metabolic syndrome during aging
PendingUS20220281902A1High blood levelGood blood pressureOrganic active ingredientsMetabolism disorderPancreatic hormoneIncrease blood pressure
Compounds, compositions and methods are provided for mitochondrial modulation. The subject mitochondrial modulator compounds generally include a head group linked to a charged moiety. In certain cases, the head group is a heterocyclic or a heteroaryl group. Aspects of the subject methods include a method of modulating mitochondria. Aspects of the subject methods include treating a subject having a metabolic syndrome-related disease or a symptom thereof by administering to the subject a therapeutically effective amount of a subject compound. In certain cases, the disease is selected from hyperlipidemia, type 2 diabetes, fatty liver disease, obesity, cardiovascular disease and stroke. In certain cases, the symptom is selected from abdominal obesity, insulin resistance, hyperinsulinemia, high levels of blood fats, increased blood pressure, and elevated serum lipids.
Owner:THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV
Non-invasive and selective bioelectronic control of blood pressure
ActiveUS10806920B2Increase ratingsLower blood pressureEvaluation of blood vesselsSensorsDecreasing heart rateNon invasive
Methods and systems for non-invasive selective control of blood pressure are described. For example, noninvasive stimulation of the auriculotemporal nerve (on the surface of the ear) facilitates a decrease in blood pressure without a corresponding decrease in heart rate or breathing rate, as occurs in stimulation of the cervical vagus and trigeminal nerves. Such a therapy may be particularly beneficial during hypertensive crises or like events where the body naturally decreases heart rate and breathing rate to compensate for an increased blood pressure.
Owner:BATTELLE MEMORIAL INST
Noninvasive angioplasty using momentary vacuum therapy
InactiveUS20070260110A1Prevents the breakdown of these chemical messagesIncrease elasticityElcosanoid active ingredientsDiagnosticsFunctional disturbanceDisease
Noninvasive angioplasty using momentary vacuum therapy (MVT) is applied to treat erectile dysfunction, peripheral artery disease, and deep vein thrombosis. MVT is a noninvasive angioplasty technique which momentarily increases blood pressure to flatten arterial plaque and increase arterial elasticity for peripheral artery disease and deep vein thrombosis. The workload on the heart will be reduced by the flattening of plaque and the increase in elasticity of the peripheral arteries. The reduction in workload may be a treatment for congestive heart failure (heart failure). For treating erectile dysfunction, MVT increases the elasticity of penile arteries but does not flatten penile plaque; when treating erectile dysfunction with MVT, only an increase in arterial elasticity is required.
Owner:KOENIG J FR +1
Drug recommendation method, device and server based on literature data
ActiveCN106156482BIncrease awarenessHigh blood pressureMedical data miningDrug and medicationsIsomerismsCrowds
The invention provides a drug recommendation method, device and server based on literature data. The method includes the steps that abstract data of all articles in a biomedicine literature database is obtained; an abstract database of articles related to a certain special people group with hypertension is set up by limiting medical subject headings; data indexes for evaluating quality of the articles related to the certain special people group with hypertension are set up; the article, author, periodical and print type in all the articles related to the certain special people group with hypertension and information of various kinds of antihypertensive drugs are extracted according to the abstract database; weighted isomerism graphs are constructed according to the extracted information and the data indexes; the weighted isomerism graphs are sorted, and ranking information of the antihypertensive drugs suitable for the certain special people group with hypertension is obtained. The method can recommend ranking information of the antihypertensive drugs suitable for the various special people groups to improve the cognition degree to use conditions of the antihypertensive drugs of grass-roots doctors, increase blood pressure rate of reaching the standard and improve the current situation of poor control over hypertension.
Owner:袁洪
Nerve-soothing blood-pressure-reducing traditional Chinese medicine tea
The invention relates to a blood-pressure-treating traditional Chinese medicine composition, and specifically relates to a nerve-soothing blood-pressure-reducing traditional Chinese medicine tea. The invention provides the tea aiming at solving a series of health problems caused by increased blood pressure due to higher mental dysfunction caused by fast life pace, increased work pressure, and inappropriate diet and rest. The nerve-soothing blood-pressure-reducing traditional Chinese medicine tea is composed of the raw materials, by weight: 30-120 parts of mulberry leaves, 25-125 parts of hawthorn leaves, 20-100 parts of eucommia leaves, 20-100 parts of Japanese pogodatree flower, 15-75 parts of white chrysanthemum, 10-50 parts of Szechwan lovage rhizome, 10-50 parts of obtuseleaf senna seed, and 10-50 parts of ginkgo leaves. When the nerve-soothing blood-pressure-reducing tea provided by the invention is taken for a long time, human body functioning can be gradually improved. The tea has the functions of human central nervou regulating, fatigue relieving, sleep promoting, body immunity enhancing, human body self-regulation enhancing, and blood pressure fluctuation suppressing.
Owner:康禾椹科技有限公司
Novel liquid medicine capable of treating cancer and having many other effects
InactiveCN108143749AInhibition of complicationsLower blood sugar concentrationMetabolism disorderInorganic phosphorous active ingredientsIn vivoHepatitis B virus
The invention discloses novel liquid medicine capable of treating cancer and having many other effects. The novel liquid medicine is prepared by using disodium hydrogen phosphate, carbonized hair andwater according to a certain proportion. The novel liquid medicine has the advantages that the new liquid medicine can be intermittently taken by cancer patients for a long time to treat cancer and prevent massive hemorrhage caused by tissue wounds formed after the cancer is dissolved, can be taken by patients with diabetes type I to inhibit the complication of the diabetes type I, can be taken bypatients with diabetes type II to lower blood sugar concentration, can be taken by hypertension patients to lower blood pressure, can be taken by hypotension patients to increase blood pressure, canbe taken by patients who have a cold to inhibit cold viruses, can be taken by patients with in-vivo herpes viruses and hepatitis B viruses to inhibit the herpes viruses and hepatitis B viruses, and can treat various other chronic diseases; the novel liquid medicine can also be intermittently taken by common people to achieve a healthcare effect, and the people who take the liquid medicine can havephysical and psychological health and pleasure and can be rejuvenated; the people who begin taking the liquid medicine need to be guided by staff with professional knowledge and skills and can take the liquid medicine by themselves after they master the main points; the effective liquid medicine is prepared on the basis of the scientific theoretical knowledge of the inventor and through constantmassive interest observation, logical highly-initiative analysis, judgment and reasoning, self-trial and trials on other people and constant improvement by the inventor, and the novel liquid medicineis an updated and original invention of the inventor.
Owner:宗如华
Stable pharmaceutical composition of vasopressin
ActiveUS20210008152A1Maintain stabilityIncrease pressurePeptide/protein ingredientsPharmaceutical delivery mechanismVascular dilationPharmaceutical medicine
The present invention relates to a stable pharmaceutical composition comprising vasopressin or pharmaceutically acceptable salts thereof. The present invention further provides a method of increasing blood pressure in adults with vasodilatory shock by administering said pharmaceutical composition of vasopressin or pharmaceutically acceptable salts thereof.
Owner:MANKIND PHARMA LTD
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com